AS

Alun John Smith

RE Respivert: 2 patents #13 of 32Top 45%
KL Kalvista Pharmaceuticals Limited: 1 patents #7 of 16Top 45%
Overall (2017): #86,779 of 506,227Top 20%
3
Patents 2017

Issued Patents 2017

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
9745306 2-((4-amino-3-(3-fluoro-5-hydroxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl)methyl)-3-(2-(trifluoromethyl)benzyl) quinazolin-4(3H)-one derivatives and their use as phosphoinositide 3-kinase inhibitors Rudy Laurent Maria Broeckx, Alex Herman Copmans, David Michel Adrien Taddei, Stuart Thomas Onions 2017-08-29
9556184 Phosphoinositide 3-kinase inhibitors David Michel Adrien Taddei, Stuart Thomas Onions, Alex Herman Copmans, Rudy Laurent Maria Broeckx 2017-01-31
9533987 Heterocyclic derivates Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Simon Teanby Hodgson, Iain Robert MILLER +2 more 2017-01-03